System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+949 today

System

Livenow

Terminal Asset View

stockNASDAQ

NTLA

$12.76-0.70%

Intellia Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

37Neutral

Live Analysis Active

Company Mission

Intellia Therapeutics creates gene-editing treatments that fix faulty DNA to cure genetic diseases. Doctors and patients use these therapies for conditions like sickle cell anemia, aiming for long-term health improvements. The company makes money by partnering with other drug companies and selling approved treatments, with revenue depending on successful research and regulatory approvals.

NTL

Industry Context

Intellia Therapeutics operates in the biotechnology sector, focusing on gene-editing technologies. This industry involves developing treatments that modify genetic material to cure diseases. Companies like Intellia often partner with larger pharmaceutical firms to fund research and share profits from successful therapies.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

83Matrix

Market Momentum

47.7— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-0.70%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing NTLA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 01:58 AM UTC

Develops gene-editing therapies to treat genetic diseases by modifying DNA, earning revenue through partnerships and potential drug sales.

Technical Pattern is forming near $13, suggesting Bullish momentum as it aligns with industry recovery. Watch for price breaking above this level.

Volume spiked 2x at $30, indicating Buyer interest because of positive clinical trial news. Monitor if volume stays above average.

Industry Trend is driving strength, with price holding above $13, signaling growth in biotech. Watch for sector momentum.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...